| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2950 | 2′-Deoxy-L-uridine |
2950.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.
|
|
|
||
| Molar Mass: 228.07 | ||
| C9H12N2O5 | ||
| [31501-19-6] | ||
| Colourless solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-L-erythro-pentofuranosyl) |
||
|
Synonymes: 1-(2′-Deoxy-β-L-erythro-pentofuranosyl)uracil; 2′-Deoxy-L-uridine; β-L-2′-deoxyuridine |
||
|
Literature: 1. Spadari S. et al. L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J. Med. Chem. 1992, 35, 4214-4220. |
||
| 2. Maga G. et al. Lack of stereospecificity of suid pseudorabies virus thymidine kinase. Biochem. J. 1993, 294, 381-385. | ||
| 3. Kouni M.H. et al. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii. Biochem. Pharmacol. 1996, 51, 1687-1700. | ||
| 4. Verri A. et al. Lack of enantiospecificity of human 2′-deoxycytidine kinase: relevance for the activation of beta.-L-deoxycytidine analogs as antineoplastic and antiviral agents. Mol. Pharmacol. 1997, 51, 132-138. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1